NASDAQ: CLSN       Celsion Corp
Last Price Today's Change   Day's Range   Trading Volume
1.639   +0.364 (28.55%)  0.912 - 2.80  133,282,928


Avg Volume (4 weeks):5,822,217
4 Weeks Range:0.67 - 2.80
4 Weeks Price Volatility (%):
52 Weeks Range:0.43 - 6.50
52 Weeks Price Volatility (%):
Average Price Target: 6.00
Price Target Upside/Downside: +4.361


No recent Headlines for this stock.

Business Background

Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1992  4382  274  3253 

Top 10 Active Counters
 NAKD 0.49+0.054 
 F 11.62+0.76 
 ACST 0.848+0.092 
 BBIG 6.29+4.75 
 LK 1.38+1.38 
 CLSN 1.639+0.364 
 CTRM 0.355+0.03 
 WPX 9.43+0.48 
 ADTX 4.71+2.10 
 SNDL 0.656-0.025